Sweden and the Netherlands complete their ePI pilots
date: 31/05/2024
The Dutch Medicines Agency (Medicines Evaluation Board) and the Swedish Medicines Agency (Medical Products Agency) have now published electronic product information, ePI, for their regulatory procedures in scope for the one-year pilot initiative by European Medicines Regulatory Network (a total of 5 procedures for each authority). The published ePIs can be viewed at the PLM Portal and ePI data can be accessed via a public application programming interface.
The pilot aims to create and test ePI in regulatory procedures and is an important step towards providing medicines information for patients and healthcare professionals in an accessible, electronic, format.
Pilot procedures are still ongoing at EMA and the national authorities in Denmark. The pilot will conclude in July 2024 and the outcomes will inform progress towards implementation of ePI.
More information on the pilot is available at EMA, MEB and MPA websites.
The pilot aims to create and test ePI in regulatory procedures and is an important step towards providing medicines information for patients and healthcare professionals in an accessible, electronic, format.
Pilot procedures are still ongoing at EMA and the national authorities in Denmark. The pilot will conclude in July 2024 and the outcomes will inform progress towards implementation of ePI.
More information on the pilot is available at EMA, MEB and MPA websites.